Reaction
Auditory Disorder reporting signals
As of the last recalculation, Auditory Disorder appears in 1,391 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is APIXABAN (PRR 17.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Apixaban | 74 | 17.4 | 17.4 |
| Valproate Sodium | 22 | 16.2 | 16.2 |
| Methimazole | 7 | 13.4 | 13.4 |
| Tafamidis | 7 | 8.9 | 8.9 |
| Faricimab | 4 | 7.4 | 7.4 |
| Ozanimod Hydrochloride | 4 | 7.2 | 7.2 |
| Regorafenib | 5 | 6.5 | 6.5 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 6 | 5.8 | 5.8 |
| Iohexol | 3 | 5.4 | 5.4 |
| Bosutinib | 3 | 5.0 | 5.0 |
| Vilazodone Hydrochloride | 3 | 4.9 | 4.9 |
| Glecaprevir And Pibrentasvir | 3 | 4.1 | 4.1 |
| Lifitegrast | 4 | 3.7 | 3.7 |
| Crizotinib | 3 | 3.5 | 3.5 |
| Esketamine Hydrochloride | 3 | 2.5 | 2.5 |
| Nirmatrelvir And Ritonavir | 6 | 1.7 | 1.7 |